De. Epps et al., A GENERAL, WIDE-RANGE SPECTROFLUOROMETRIC METHOD FOR MEASURING THE SITE-SPECIFIC AFFINITIES OF DRUGS TOWARD HUMAN SERUM-ALBUMIN, Analytical biochemistry, 227(2), 1995, pp. 342-350
Binding of drugs to serum albumin is one of the most important pharmac
okinetic determinants and the design of drugs should take advantage of
this property. In the present work, the fluorescent ligands Warfarin
and dansylsulfonamide were used as probes of IIA site of human albumin
and dansylsarcosine as the probe of the IIIA site. From the changes i
n fluorescence upon binding at 37 degrees C, pH 7.4, the following dis
sociation constants were determined: Warfarin, 3.43 +/- 0.69 mu M; dan
sylsulfonamide, 7.57 +/- 0.88 mu M; and dansylsarcosine, 6.06 +/- 1.09
mu M. Nonfluorescent ligands displace these probes competitively and
the type of probe displaced identifies the site specificity of the Lig
ands. Nonlinear least-squares analysis of the decrease in fluorescence
accompanying the displacement yields the stoichiometry and the dissoc
iation constants. The dissociation constant may also be estimated rapi
dly from displacement at a single competitor concentration. The method
yields reliable K-d values for at least the range of 0.2 to 100 mu M.
Representative dissociation constants for the IIA site-specific Ligan
ds are as follows: phenylbutazone, 1.9 +/- 0.3 mu M; U-99,499, 1.8 +/-
0.2 mu M; U-96,988, 5.3 +/- 1.5 mu M; and U-105,665, 42 +/- 7 mu M. F
or the IIIA site we find the following K-d values: oxazepam, 27.7 +/-
2.1 mu M; diazepam, 7.7 +/- 1.0 mu M; and ibuprofen, 2.7 +/- 1.2 mu M.
The method is eminently suitable for large-scale screening. (C) 1995
Academic Press, Inc.